<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tan JL</submitter><funding>Howard Hughes Medical Institute</funding><funding>NIAID NIH HHS</funding><funding>NIEHS NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NHGRI NIH HHS</funding><funding>NCI NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>34-46</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4836061</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>62(1)</volume><pubmed_abstract>Studying cancer metabolism gives insight into tumorigenic survival mechanisms and susceptibilities. In melanoma, we identify HEXIM1, a transcription elongation regulator, as a melanoma tumor suppressor that responds to nucleotide stress. HEXIM1 expression is low in melanoma. Its overexpression in a zebrafish melanoma model suppresses cancer formation, while its inactivation accelerates tumor onset in vivo. Knockdown of HEXIM1 rescues zebrafish neural crest defects and human melanoma proliferation defects that arise from nucleotide depletion. Under nucleotide stress, HEXIM1 is induced to form an inhibitory complex with P-TEFb, the kinase that initiates transcription elongation, to inhibit elongation at tumorigenic genes. The resulting alteration in gene expression also causes anti-tumorigen</pubmed_abstract><journal>Molecular cell</journal><pubmed_title>Stress from Nucleotide Depletion Activates the Transcriptional Regulator HEXIM1 to Suppress Melanoma.</pubmed_title><pmcid>PMC4836061</pmcid><funding_grant_id>R01-HG004361</funding_grant_id><funding_grant_id>R01CA140485</funding_grant_id><funding_grant_id>2P01CA120964</funding_grant_id><funding_grant_id>R01 HL048801</funding_grant_id><funding_grant_id>P30 CA006516</funding_grant_id><funding_grant_id>5P30CA006516</funding_grant_id><funding_grant_id>P50 GM082250</funding_grant_id><funding_grant_id>T32 GM007324</funding_grant_id><funding_grant_id>R01CA103846</funding_grant_id><funding_grant_id>R21 AI107067</funding_grant_id><funding_grant_id>P01 CA120964</funding_grant_id><funding_grant_id>R01 CA103846</funding_grant_id><funding_grant_id>R21AI107067</funding_grant_id><funding_grant_id>R01 CA140485</funding_grant_id><funding_grant_id>P30 CA014051</funding_grant_id><funding_grant_id>R01 AI125104</funding_grant_id><funding_grant_id>R01-ES023168</funding_grant_id><funding_grant_id>R01 GM035500</funding_grant_id><pubmed_authors>Brogie JE</pubmed_authors><pubmed_authors>Laga AC</pubmed_authors><pubmed_authors>Shyh-Chang N</pubmed_authors><pubmed_authors>Saint-Andre V</pubmed_authors><pubmed_authors>Santoriello C</pubmed_authors><pubmed_authors>Pandolfi PP</pubmed_authors><pubmed_authors>Hagedorn EJ</pubmed_authors><pubmed_authors>Do BT</pubmed_authors><pubmed_authors>Kim YJ</pubmed_authors><pubmed_authors>Young RA</pubmed_authors><pubmed_authors>Fogley RD</pubmed_authors><pubmed_authors>van Rooijen E</pubmed_authors><pubmed_authors>Tan JL</pubmed_authors><pubmed_authors>Fujinaga K</pubmed_authors><pubmed_authors>Pandell N</pubmed_authors><pubmed_authors>Chang HY</pubmed_authors><pubmed_authors>Zon LI</pubmed_authors><pubmed_authors>Ablain J</pubmed_authors><pubmed_authors>Price DH</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Greer CB</pubmed_authors><pubmed_authors>Peterlin BM</pubmed_authors><pubmed_authors>Kim TH</pubmed_authors><pubmed_authors>Flynn RA</pubmed_authors><pubmed_authors>Asara JM</pubmed_authors><pubmed_authors>Bothmer A</pubmed_authors><pubmed_authors>Clohessy JG</pubmed_authors><pubmed_authors>Yang S</pubmed_authors><pubmed_authors>White RM</pubmed_authors><pubmed_authors>Fan ZP</pubmed_authors><pubmed_authors>Avagyan S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Stress from Nucleotide Depletion Activates the Transcriptional Regulator HEXIM1 to Suppress Melanoma.</name><description>Studying cancer metabolism gives insight into tumorigenic survival mechanisms and susceptibilities. In melanoma, we identify HEXIM1, a transcription elongation regulator, as a melanoma tumor suppressor that responds to nucleotide stress. HEXIM1 expression is low in melanoma. Its overexpression in a zebrafish melanoma model suppresses cancer formation, while its inactivation accelerates tumor onset in vivo. Knockdown of HEXIM1 rescues zebrafish neural crest defects and human melanoma proliferation defects that arise from nucleotide depletion. Under nucleotide stress, HEXIM1 is induced to form an inhibitory complex with P-TEFb, the kinase that initiates transcription elongation, to inhibit elongation at tumorigenic genes. The resulting alteration in gene expression also causes anti-tumorigen</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Apr</publication><modification>2026-04-15T11:30:41.409Z</modification><creation>2019-03-27T02:11:54Z</creation></dates><accession>S-EPMC4836061</accession><cross_references><pubmed>27058786</pubmed><doi>10.1016/j.molcel.2016.03.013</doi></cross_references></HashMap>